Strategic partnerships Zuellig Pharma has a track record of expanding distribution capabilities through partnerships (e.g., with Delex Pharma in the Philippines and multiple medical associations). This presents a sales opportunity to offer co-branded distribution or value-add services to new partners seeking broader market access.

Public health coalition Active engagement with national medical societies and patient advocacy coalitions signals openness to collaborative programs, potential for joint patient outreach, and opportunities to provide distribution and clinical trial support services to government or NGO initiatives.

Regional scale With over 5,000 employees and operations across Asia, Zuellig Pharma demonstrates significant regional reach, making it a potential channel for manufacturers seeking fast, compliant access to multiple Asian markets via a single distribution and commercialization partner.

Digital transformation A tech stack including SAP SuccessFactors, Salesforce, Tableau, and Mixpanel indicates maturity in data-driven sales and operations. This suggests opportunities to offer advanced analytics, CRM optimization, and digital marketing automation to improve market access and performance.

Legacy and infrastructure Historical strengths such as the Changi warehouse and established distribution networks point to reliable logistics capabilities. Vendors and manufacturers can leverage this backbone for scalable supply chain solutions, warehousing, and streamlined clinical trial support across Southeast Asia.